#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vascular malformation Acute graft versus host disease in liver Leukoencephalopathy Cognitive disorder Hypersomnia Juvenile psoriatic arthritis Osteosarcoma recurrent Prader-Willi syndrome Liposarcoma metastatic Hypoxic-ischaemic encephalopathy Anal fistula Glioblastoma multiforme Metastases to peritoneum Duchenne muscular dystrophy gene carrier Pyruvate dehydrogenase complex deficiency More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Basic Information Alveolar rhabdomyosarcoma – Diagnostics Chordoma – Diagnostics Lysosomal storage disorder – Treatment Medulloblastoma recurrent – Life with Disease CADASIL – Basic Information Hereditary hypophosphataemic rickets – Trials in Disease Arterial tortuosity syndrome – Trials in Disease Antithrombin III deficiency – Trials in Disease Breast angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elacestrant Dihydrochloride Io102 Hydrochloride Methylphenidate Hydrochloride Empasiprubart Milrinone Emrusolmin ANTI-GD2-800CW Vibozilimod Palivizumab Baricitinib Venglustat Cetrelimab Tolu Balsam Entecavir Treg02 Acetazolamide Ecoo6A Carisbamate IPN01195 Prednisolone More therapies…

    Learn about Your Condition

    Diabetic retinopathy Renal cancer metastatic Latent tuberculosis Pigmentary glaucoma Burning mouth syndrome Malignant neoplasm of choroid Stem cell transplant Cerebral amyloid angiopathy Thalassaemia Polycystic ovarian syndrome Hyperphagia Haemofiltration Meningioma Nervous system disorder Circulatory collapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Superficial spreading melanoma stage III

  • Study on the Effectiveness of L19IL2 and L19TNF Injections with Surgery for Patients with Stage IIIB/C Melanoma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bifikafusp Alfa
    • Onfekafusp Alfa
    Germany Italy Spain Sweden

  • Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Desmoplastic melanoma
    • Malignant melanoma of eyelid
    • Melanoma recurrent
    Investigated Drugs:
    • Atl001
    • Nivolumab
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!